Sarepta Therapeutics Announces Publication of Positive Long-Term Safety and Efficacy Data for Eteplirsen in the Annals of Neurology

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/17/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. TLT
10. AMZN

Go back to Sarepta Therapeutics Announces Publication of Positive Long-Term Safety and Efficacy Data for Eteplirsen in the Annals of Neurology
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 20.67 +0.91 (4.61%)
Previous Close $19.76    52 Week High $63.73 
Open $20.23    52 Week Low $8.00 
Day High $21.75    P/E N/A 
Day Low $19.97    EPS $-5.69 
Volume 2,588,046